Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0000950170-24-107771
Filing Date
2024-09-18
Accepted
2024-09-18 16:05:13
Documents
18
Period of Report
2024-09-18

Document Format Files

Seq Description Document Type Size
1 PRE 14A onvo-20240918.htm   iXBRL PRE 14A 1456991
2 GRAPHIC img64649285_0.jpg GRAPHIC 5195
3 GRAPHIC img64649285_1.jpg GRAPHIC 2761
4 GRAPHIC img64649285_2.jpg GRAPHIC 161611
5 GRAPHIC img64649285_3.jpg GRAPHIC 162434
6 GRAPHIC img64649285_4.jpg GRAPHIC 235384
7 GRAPHIC img64649285_5.jpg GRAPHIC 226114
  Complete submission text file 0000950170-24-107771.txt   4103224

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT onvo-20240918.xsd EX-101.SCH 25725
20 EXTRACTED XBRL INSTANCE DOCUMENT onvo-20240918_htm.xml XML 235676
Mailing Address 11555 SORRENTO VALLEY ROAD SUITE 100 SAN DIEGO CA 92121
Business Address 11555 SORRENTO VALLEY ROAD SUITE 100 SAN DIEGO CA 92121 858-224-1000
ORGANOVO HOLDINGS, INC. (Filer) CIK: 0001497253 (see all company filings)

EIN.: 271488943 | State of Incorp.: DE | Fiscal Year End: 0331
Type: PRE 14A | Act: 34 | File No.: 001-35996 | Film No.: 241307455
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)